Suchergebnisse - "Subramanian, Sreedhar"

PubPharm (11)

1

The Long View : 2-Year Outcomes of Mirikizumab for Ulcerative Colitis

enthalten in: Inflammatory bowel diseases | 2024

von Pillay, L. | Subramanian, S.

2

Ambulatory Management of Acute Severe Ulcerative Colitis : A Pandemic-driven Initiative

enthalten in: Inflammatory bowel diseases | 2020

von Townsend, T. | Fiske, J. | Collins, P. | +5

CommentOn: Inflamm Bowel Dis. 2020 May 12;26(6):793-796. - PMID 32314792

3

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

enthalten in: Inflammatory bowel diseases | 2018

von Irving, P. | Iqbal, T. | Nwokolo, C. | +9

4

Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use

enthalten in: Inflammatory bowel diseases | 2016

von Subramanian, S. | Asher, R. | Weston, W. | +8

CommentIn: Inflamm Bowel Dis. 2016 Nov;22(11):E42-E43. - PMID 27755274

5

Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use

enthalten in: Inflammatory bowel diseases | 2016

von Subramanian, S. | Asher, R. | Weston, W. | +8

6

Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use

enthalten in: Inflammatory bowel diseases | 2016

von Subramanian, S. | Asher, R. | Weston, W. | +8

7

Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D

enthalten in: Inflammatory bowel diseases | 2015

von Flanagan, P. | Chiewchengchol, D. | Wright, H. | +6

8

Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D

enthalten in: Inflammatory bowel diseases | 2015

von Flanagan, P. | Chiewchengchol, D. | Wright, H. | +6

9

Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent

enthalten in: Inflammatory bowel diseases | 2011

von Subramanian, S. | Yajnik, V. | Sands, B. | +2

10

Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine

enthalten in: Inflammatory bowel diseases | 2008

von Subramanian, S. | Rhodes, J. | Hart, C. | +7